TFC Financial Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.15K Hold
57
– – ﹤0.01% 487
2026
Q2
$2.19K Hold
57
– – ﹤0.01% 563
2026
Q1
$1.21K Hold
57
– – ﹤0.01% 593
2025
Q4
$930 Buy
57
+1
+2% +$15 ﹤0.01% 605
2025
Q3
$655 Hold
56
– – ﹤0.01% 676
2025
Q2
$649 Buy
+56
New +$510 ﹤0.01% 639
2023
Q3
– Sell
-6
Closed -$336 – 702
2023
Q2
$336 Buy
+6
New +$325 ﹤0.01% 632

Other funds holding TXG

TFC Financial Management's TXG Position: Q3 2026 in Review

TFC Financial Management held its 10x Genomics (TXG) position steady in Q3 2026 at 57 shares worth $5.15K. The position accounts for ﹤0.01% of the portfolio, ranked #487.

TFC Financial Management first reported a position in TXG in Q2 2023 and has held it in 7 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • TFC Financial Management held 57 shares of 10x Genomics worth $5.15K as of Q3 2026.
  • TFC Financial Management left its 10x Genomics share count unchanged in Q3 2026.
  • 10x Genomics made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #487 holding.
  • TFC Financial Management first reported a position in 10x Genomics in Q2 2023 and has held it in 7 quarters since.
  • 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.